Pharma Voice2d agobullish
Former Ovid CEO Dr. Jeremy Levin’s rallying cry for biotechThe long-time pharma exec is on a quest with a new book and bold message for biotech leaders and U.S. lawmakers.
Notícias
Apenas manchetes de alto sinal — eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
53last 24h
1680last 7d
314🟢 bullish (7d)
170🔴 bearish (7d)
136publishers
Insider Monkey5d agobullish
Bristol-Myers Squibb Company (BMY) Myers Beats Quarterly Profit EstimatesBristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen. On April 30, 2026, Reuters reported that Bristol-Myers Squibb Company (NYSE:BMY) announced first-quarter adjusted earnings of $1.58 per share, which came in above analysts’ average estimate of $1.42. The revenue of $11.49 billion also exceeded […]
